Match!

Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain

Published on May 1, 2004in European Journal of Neuroscience2.784
· DOI :10.1111/j.0953-816X.2004.03365.x
Jane E . Swatton3
Estimated H-index: 3
(Babraham Institute),
Lynda A. Sellers22
Estimated H-index: 22
(Babraham Institute)
+ 3 AuthorsSabine Bahn55
Estimated H-index: 55
(University of Cambridge)
Abstract
Introduction Abnormal phosphorylation of tau is a feature of Alzheimer's disease (AD), which develops prematurely in Down syndrome (DS) patients. Cognitive impairment is also recognized as a clinical characteristic of schizophrenia, which does not appear to be associated with tau-aggregate formation. Several kinases can phosphorylate tau in cell-free assays. Here we show increased activity of mitogen-activated protein kinases (MAPKs) (including ERK½, SAPKs and p38) in post mortem AD and DS brains, which could not be accounted for by expression changes. In contrast, glycogen synthase kinase-3 activity (GSK-3αβ) was reduced significantly. Examination of tau in AD and DS using antibodies selective for MAPK phosphorylation sites showed increased immunoreactivity. In addition, phosphorylation of S 1 9 9 , reportedly a selective substrate for cyclin-dependent kinase-5 (cdk5) or GSK-3αβ was only observed in AD samples, which showed a concomitant increase in the expression of p25, the enhancing cofactor for cdk5 activity. However, in schizophrenia brain, MAPK-phosphorylated tau was unchanged compared to matched controls, despite similar expression levels to those in AD. The activities of the MAPKs and GSK-3αβ were also unchanged. These data demonstrate that in AD and DS, enhanced MAPK activity, which has an established role in regulating neuronal plasticity and survival, can account for irregular tau phosphorylation, and that the molecular processes involved in these neurodegenerative disorders are distinct from those in schizophrenia. These data also question the significance of GSK-3αβ, as much previous work carried out in vitro has placed this kinase as a favoured candidate for involvement in the pathological phosphorylation of tau.
  • References (39)
  • Citations (108)
📖 Papers frequently viewed together
199943.07Nature
1,220 Citations
200314.40Neuron
5 Authors (Jonathan C. Cruz, ..., Li-Huei Tsai)
442 Citations
74 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References39
Newest
#1Xiongwei Zhu (Case Western Reserve University)H-Index: 82
#2Catherine A. Rottkamp (Case Western Reserve University)H-Index: 19
Last. Mark Smith (Case Western Reserve University)H-Index: 66
view all 9 authors...
Mitogen-activated protein kinase (MAPK) p38 has been implicated in the pathogenesis of Alzheimer's disease, but the upstream cascade leading to p38 activation has not been elucidated in the disease. In the present study, we focused on mitogen-activated protein kinase kinase 6 (MKK6), one of the upstream activators of p38 MAPK. We found that MKK6 was not only increased but also specifically associated with granular structures in the susceptible neurons in the hippocampus and cortex of Alzheimer's...
126 CitationsSource
#1Isidre Ferrer (University of Barcelona)H-Index: 75
#2R. BlancoH-Index: 15
Last. Teresa Ribalta (University of Barcelona)H-Index: 29
view all 10 authors...
Abnormal tau phosphorylation and deposition in neurones and glial cells is one of the major features in tau pathies. The present study examines the involvement of the Ras/MEK/ERK pathway of tau phosphorylation in Alzheimer disease (AD), Pick's disease (PiD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), by Western blotting, single and double-labelling immunohistochemistry, and p21Ras activation assay. Since this pathway is also activated in several paradigms of cell d...
173 CitationsSource
#1Neville MarksH-Index: 16
#2Martin J. Berg (NYU: New York University)H-Index: 3
Secretases degrade amyloid precursor protein (APP) releasing fragments (β-peptides Aβ, Aβx) that assemble to form hallmark extracellular deposits in Alzheimer's disease (AD) correlating with disease severity. As such, secretases supply targets for therapeutic intervention and form the focus of this overview. Progress in elucidating secretases and their modes of catalysis come from exploiting the use of transgenics or transfected cells. In addition to Aβx, secretases also release C-terminal fragm...
11 CitationsSource
#1Christopher J. Phiel (HHMI: Howard Hughes Medical Institute)H-Index: 16
#2Christina A. Wilson (UPenn: University of Pennsylvania)H-Index: 10
Last. Peter S. Klein (HHMI: Howard Hughes Medical Institute)H-Index: 56
view all 4 authors...
Alzheimer's disease is associated with increased production and aggregation of amyloid-β (Aβ) peptides1. Aβ peptides are derived from the amyloid precursor protein (APP) by sequential proteolysis, catalysed by the aspartyl protease BACE2, followed by presenilin-dependent γ-secretase cleavage3. Presenilin interacts with nicastrin4,5, APH-1 and PEN-2 (ref. 6), all of which are required for γ-secretase function. Presenilins also interact with α-catenin, β-catenin7,8 and glycogen synthase kinase-3β ...
899 CitationsSource
Glycogen synthase kinase 3 (GSK-3) is a multifunctional serine/threonine kinase found in all eukaryotes. The enzyme is a key regulator of numerous signalling pathways, including cellular responses to Wnt, receptor tyrosine kinases and G-protein-coupled receptors and is involved in a wide range of cellular processes, ranging from glycogen metabolism to cell cycle regulation and proliferation. GSK-3 is unusual in that it is normally active in cells and is primarily regulated through inhibition of ...
1,584 CitationsSource
#1Othman Ghribi (UVA: University of Virginia)H-Index: 35
#2Mary M. Herman (NIH: National Institutes of Health)H-Index: 59
Last. John Savory (UVA: University of Virginia)H-Index: 36
view all 3 authors...
The goal of this study was to assess the in vivo effect of Aβ on apoptosis pathways involving the endoplasmic reticulum and mitochondria, and its relationship to the induction of tau phosphorylation and DNA oxidative damage. In rabbits treated intracisternally with aggregated Aβ(1–42), clear evidence of endoplasmic reticulum stress was observed by the activation of caspase-12 and cleavage of caspase-3 in the endoplasmic reticulum. Mitochondrial injury was evident from the release of cytochrome c...
58 CitationsSource
#1Christos Pantelis (Mental Health Research Institute)H-Index: 104
#2Dennis Velakoulis (Mental Health Research Institute)H-Index: 61
Last. Philip McGuireH-Index: 116
view all 12 authors...
Summary Background Psychotic disorders, such as schizophrenia, are associated with neuroanatomical abnormalities, but whether these predate the onset of symptoms or develop progressively over the course of illness is unclear. We investigated this issue with MRI to study people with prodromal symptoms who are at ultra high-risk for the development of psychosis. Methods We did two comparisons, cross-sectional and longitudinal. For the cross-sectional comparison, 75 people with prodromal signs of p...
1,020 CitationsSource
#1Jin-Jing Pei (KI: Karolinska Institutet)H-Index: 29
#2Heiko Braak (Goethe University Frankfurt)H-Index: 100
Last. Inge Grundke-IqbalH-Index: 86
view all 7 authors...
Abstract The abnormal hyperphosphorylation of tau in Alzheimer’s disease (AD) has been proposed to involve the extracellular-signal-regulated protein kinase (ERK) of the mitogen-activated protein (MAP) kinase family. ERK is phosphorylated and thereby activated by MAP kinase kinase (MEK). In the present study, we determined the intracellular and regional distribution of the active forms of both MEK1/2 and ERK1/2, i.e. p-MEK1/2 and p-ERK1/2 in the entorhinal, hippocampal, and temporal cortices of ...
166 CitationsSource
#1Diane P. HangerH-Index: 47
#2Joanna C. BettsH-Index: 2
Last. Brian H. AndertonH-Index: 65
view all 5 authors...
Abstract: Paired helical filaments (PHFs) are the structural constituents of neurofibrillary tangles in Alzheimer's disease and are composed of hyperphosphorylated forms of the microtubule-associated protein tau (PHF-tau). Pathological hyperphosphorylation of tau is believed to be an important contributor to the destabilisation of microtubules and their subsequent disappearance from tangle-bearing neurons in Alzheimer's disease, making elucidation of the mechanisms that regulate tau phosphorylat...
276 CitationsSource
#1Fei LiuH-Index: 46
#2Khalid IqbalH-Index: 89
Last. Cheng-Xin GongH-Index: 54
view all 4 authors...
Microtubule-associated protein tau is abnormally hy- perphosphorylated, glycosylated, and aggregated in aiected neurons in the brains of individuals with Alzheimer's disease (AD).We recently found that the glycosylation might precede hyperphosphorylation of tau in AD.In this study, we investi- gated the eiect of glycosylation on phosphorylation of tau cat- alyzed by cyclin-dependent kinase 5 (cdk5) and glycogen syn- thase kinase-3L (GSK-3L).The phosphorylation of the longest isoform of recombina...
124 CitationsSource
Cited By108
Newest
#1Dongmei Chen (Fujian Medical University)H-Index: 1
#2Yingxue Mei (Fujian Medical University)
Last. Chun Lin (Fujian Medical University)
view all 14 authors...
Death-associated protein kinase 1 (DAPK1) is upregulated in the brains of human Alzheimer's disease (AD) patients compared with normal subjects, and aberrant DAPK1 regulation is implicated in the development of AD. However, little is known about whether and how DAPK1 function is regulated in AD. Here, we identified melatonin as a critical regulator of DAPK1 levels and function. Melatonin significantly decreases DAPK1 expression in a post-transcriptional manner in neuronal cell lines and mouse pr...
Source
#1Tushar Arora (National Brain Research Centre)
#2Pablo Caviedes (University of Chile)H-Index: 21
Last. Shiv K. Sharma (National Brain Research Centre)H-Index: 7
view all 3 authors...
Down syndrome (DS) is a developmental disorder that results from the trisomy of chromosome 21. DS patients show several abnormalities including cognitive deficits. Here, we show enhanced activation of the extracellular signal-regulated kinase (ERK), a kinase that critically regulates synaptic plasticity and memory, in a hippocampal cell line derived from trisomy 16 mouse foetus. In addition, these cells show enhanced activation of p38 mitogen-activated protein kinase (p38 MAPK). The hyper-activa...
Source
#1Karin E. Borgmann-Winter (UPenn: University of Pennsylvania)H-Index: 17
#2Kai Wang (UPenn: University of Pennsylvania)H-Index: 30
Last. Chang-Gyu Hahn (UPenn: University of Pennsylvania)H-Index: 36
view all 6 authors...
Abstract The complex and heterogeneous pathophysiology of schizophrenia can be deconstructed by integration of large-scale datasets encompassing genes through behavioral phenotypes. Genome-wide datasets are now available for genetic, epigenetic and transcriptomic variations in schizophrenia, which are then analyzed by newly devised systems biology algorithms. A missing piece, however, is the inclusion of information on the proteome and its dynamics in schizophrenia. Proteomics has lagged behind ...
3 CitationsSource
#1Chinthalapally V. Rao (University of Oklahoma Health Sciences Center)H-Index: 56
#2Adam S. Asch (University of Oklahoma Health Sciences Center)H-Index: 30
Last. Hiroshi Yamada (University of Oklahoma Health Sciences Center)H-Index: 36
view all 4 authors...
The cell cycle and its regulators are validated targets for cancer drugs. Reagents that target cells in a specific cell cycle phase (e.g., antimitotics or DNA synthesis inhibitors/replication stress inducers) have demonstrated success as broad-spectrum anticancer drugs. Cyclin-dependent kinases (CDKs) are drivers of cell cycle transitions. A CDK inhibitor, flavopiridol/alvocidib, is an FDA-approved drug for acute myeloid leukemia. Alzheimer's disease (AD) is another serious issue in contemporary...
Source
#1Tomas Barrett (CMU: Central Michigan University)H-Index: 1
#2Yannick Marchalant (CMU: Central Michigan University)H-Index: 13
Last. Kevin H.J. Park (CMU: Central Michigan University)H-Index: 5
view all 3 authors...
Abstract Increased amyloid beta (Aβ) deposition is implicated in early stages of Alzheimer's disease (AD). Although aberrant Cdk5 activity mediated by Cdk5/p25 is suggested to promote Aβ plaque deposition, the effects of Cdk5 inhibition on Aβ plaque loads in AD mouse models have been equivocal, possibly due to the fact that Cdk5 can be activated by p35 or p39 and their cleaved products. Here we evaluated the effect of p35 knockdown on Aβ plaque formation by constitutively knocking out a single p...
Source
#1Fiorenza Stagni (UNIBO: University of Bologna)H-Index: 10
Last. Sandra Guidi (UNIBO: University of Bologna)H-Index: 20
view all 9 authors...
Abstract Down syndrome (DS), a genetic condition due to triplication of chromosome 21, is characterized by reduced proliferation of neural progenitor cells (NPCs) starting from early life stages. This defect is worsened by a reduction of neuronogenesis (accompanied by an increase in astrogliogenesis) and dendritic spine atrophy. Since this triad of defects underlies intellectual disability, it seems important to establish whether it is possible to pharmacologically correct these alterations. In ...
Source
#1Jun Sung Park (KAIST)H-Index: 1
#2Junehawk Lee (Korea Institute of Science and Technology Information)H-Index: 13
Last. Jeong Ho Lee (KAIST)H-Index: 17
view all 12 authors...
The role of brain somatic mutations in Alzheimer’s disease (AD) is not well understood. Here, we perform deep whole-exome sequencing (average read depth 584×) in 111 postmortem hippocampal formation and matched blood samples from 52 patients with AD and 11 individuals not affected by AD. The number of somatic single nucleotide variations (SNVs) in AD brain specimens increases significantly with aging, and the rate of mutation accumulation in the brain is 4.8-fold slower than that in AD blood. Th...
15 CitationsSource
#1Laura M. Taylor (UW: University of Washington)H-Index: 2
#2Pamela J. McMillan (UW: University of Washington)H-Index: 17
Last. Nicole F. Liachko (UW: University of Washington)H-Index: 11
view all 4 authors...
: A number of neurodegenerative diseases are characterized by deposition of abnormally phosphorylated tau or TDP-43 in disease-affected neurons. These diseases include Alzheimer's disease, frontotemporal lobar degeneration, and amyotrophic lateral sclerosis. No disease-modifying therapeutics is available to treat these disorders, and we have a limited understanding of the cellular and molecular factors integral to disease initiation or progression. Phosphorylated tau and TDP-43 are important mar...
Source
#1Song Chen (CPU: China Pharmaceutical University)H-Index: 12
#2Su-Ting Chen (CPU: China Pharmaceutical University)H-Index: 3
Last. Xiangdong Gao (CPU: China Pharmaceutical University)H-Index: 21
view all 8 authors...
Abstract Our understanding of the mechanisms underlying process in Alzheimer's disease (AD) is far from completion and new therapeutic targets are urgently needed. Recently, the link between dementia and diabetes mellitus (DM) prompted us to search for new therapeutic strategies from glucose metabolism regulators for neurodegeneration. Previous studies have indicated that fibroblast growth factor 21 (FGF21), an attractive and potential therapeutic treatment for DM, may exert diverse effects in t...
2 CitationsSource
#1Shuke Nie (WHU: Wuhan University)H-Index: 7
#2Kai Ma (HUST: Huazhong University of Science and Technology)H-Index: 7
Last. Xuebing Cao (HUST: Huazhong University of Science and Technology)H-Index: 15
view all 9 authors...
7,8-Dihydroxyflavone (7,8-DHF) is thought to be a promising therapeutic agent for various neurodegenerative diseases. The major purpose of this study was to investigate the neuroprotective effects of 7,8-DHF on the rotenone-induced motor deficit of Parkinson’s disease. Nine-month-old rats were treated with rotenone (2 mg/kg/day, i.h.) for 5 weeks to establish the animal model of Parkinson’s disease (PD), and 7,8-DHF (5 mg/kg, i.p.) was administrated daily throughout the whole period of rotenone ...
1 CitationsSource